Skip to main content
Top
Published in: Journal of General Internal Medicine 11/2019

01-11-2019 | Metformin | Original Research

National Survey of Primary Care Physicians’ Knowledge, Practices, and Perceptions of Prediabetes

Authors: Eva Tseng, MD, Raquel C. Greer, MD, Paul O’Rourke, MD, Hsin-Chieh Yeh, PhD, Maura M. McGuire, MD, Ann L. Albright, PhD, Jill A. Marsteller, PhD, Jeanne M. Clark, MD, Nisa M. Maruthur, MD

Published in: Journal of General Internal Medicine | Issue 11/2019

Login to get access

Abstract

Background

Despite strong evidence and national policy supporting type 2 diabetes prevention, little is known about type 2 diabetes prevention in the primary care setting.

Objective

Our objective was to assess primary care physicians’ knowledge and practice regarding perceived barriers and potential interventions to improving management of prediabetes.

Design

Cross-sectional mailed survey.

Participants

Nationally representative random sample of US primary care physicians (PCPs) identified from the American Medical Association Physician Masterfile.

Main Measures

We assessed PCP knowledge, practice behaviors, and perceptions related to prediabetes. We performed chi-square and Fisher’s exact tests to evaluate the association between PCP characteristics and the main survey outcomes.

Key Results

In total, 298 (33%) eligible participants returned the survey. PCPs had limited knowledge of risk factors for prediabetes screening, laboratory diagnostic criteria for prediabetes, and management recommendations for patients with prediabetes. Only 36% of PCPs refer patients to a diabetes prevention lifestyle change program as their initial management approach, while 43% discuss starting metformin for prediabetes. PCPs believed that barriers to type 2 diabetes prevention are both at the individual level (e.g., patients’ lack of motivation) and at the system level (e.g., lack of weight loss resources). PCPs reported that increased access to and insurance coverage of type 2 diabetes prevention programs and coordination of referral of patients to these resources would facilitate type 2 diabetes preventive efforts.

Conclusions

Addressing gaps in PCP knowledge may improve the identification and management of people with prediabetes, but system-level changes are necessary to support type 2 diabetes prevention in the primary care setting.
Literature
1.
go back to reference Centers for Disease Control and Prevention. National Diabetes Statistics Report, 2017. Atlanta, GA: Centers for Disease Control and Prevention, US Department of Health and Human Services; 2017. Centers for Disease Control and Prevention. National Diabetes Statistics Report, 2017. Atlanta, GA: Centers for Disease Control and Prevention, US Department of Health and Human Services; 2017.
2.
go back to reference Tabak AG, Herder C, Rathmann W, Brunner EJ, Kivimaki M. Prediabetes: a high-risk state for diabetes development. Lancet 2012;379(9833):2279–90.CrossRef Tabak AG, Herder C, Rathmann W, Brunner EJ, Kivimaki M. Prediabetes: a high-risk state for diabetes development. Lancet 2012;379(9833):2279–90.CrossRef
3.
go back to reference Knowler WC, Barrett-Connor E, Fowler SE, Hamman RF, Lachin JM, Walker EA, et al. Reduction in the incidence of type 2 diabetes with lifestyle intervention or metformin. N Engl J Med 2002;346(6):393–403.CrossRef Knowler WC, Barrett-Connor E, Fowler SE, Hamman RF, Lachin JM, Walker EA, et al. Reduction in the incidence of type 2 diabetes with lifestyle intervention or metformin. N Engl J Med 2002;346(6):393–403.CrossRef
4.
go back to reference Pan XR, Li GW, Hu YH, Wang JX, Yang WY, An ZX, et al. Effects of diet and exercise in preventing NIDDM in people with impaired glucose tolerance. The Da Qing IGT and Diabetes Study. Diabetes Care 1997;20(4):537–44.CrossRef Pan XR, Li GW, Hu YH, Wang JX, Yang WY, An ZX, et al. Effects of diet and exercise in preventing NIDDM in people with impaired glucose tolerance. The Da Qing IGT and Diabetes Study. Diabetes Care 1997;20(4):537–44.CrossRef
5.
go back to reference Balk EM, Earley A, Raman G, Avendano EA, Pittas AG, Remington PL. Combined Diet and Physical Activity Promotion Programs to Prevent Type 2 Diabetes Among Persons at Increased Risk: A Systematic Review for the Community Preventive Services Task Force. Ann Intern Med 2015;163(6):437–51.CrossRef Balk EM, Earley A, Raman G, Avendano EA, Pittas AG, Remington PL. Combined Diet and Physical Activity Promotion Programs to Prevent Type 2 Diabetes Among Persons at Increased Risk: A Systematic Review for the Community Preventive Services Task Force. Ann Intern Med 2015;163(6):437–51.CrossRef
6.
go back to reference Albright A. Diabetes Prevention and Management: The Thrill Is Not Gone. Diabetes Spectr 2014;27(1):63–8.CrossRef Albright A. Diabetes Prevention and Management: The Thrill Is Not Gone. Diabetes Spectr 2014;27(1):63–8.CrossRef
8.
go back to reference Centers for Disease Control and Prevention. Diabetes Report Card 2010. Atlanta, GA: Centers for Disease Control and Prevention, US Department of Health and Human Services; 2012. Centers for Disease Control and Prevention. Diabetes Report Card 2010. Atlanta, GA: Centers for Disease Control and Prevention, US Department of Health and Human Services; 2012.
9.
go back to reference Centers for Disease Control and Prevention. Diabetes Report Card 2014. Atlanta, GA: Centers for Disease Control and Prevention, US Department of Health and Human Services; 2015. Centers for Disease Control and Prevention. Diabetes Report Card 2014. Atlanta, GA: Centers for Disease Control and Prevention, US Department of Health and Human Services; 2015.
10.
go back to reference Rhee MK, Herrick K, Ziemer DC, Vaccarino V, Weintraub WS, Narayan KM, et al. Many Americans have pre-diabetes and should be considered for metformin therapy. Diabetes Care 2010;33(1):49–54.CrossRef Rhee MK, Herrick K, Ziemer DC, Vaccarino V, Weintraub WS, Narayan KM, et al. Many Americans have pre-diabetes and should be considered for metformin therapy. Diabetes Care 2010;33(1):49–54.CrossRef
11.
go back to reference Karve A, Hayward RA. Prevalence, diagnosis, and treatment of impaired fasting glucose and impaired glucose tolerance in nondiabetic U.S. adults. Diabetes Care 2010;33(11):2355–9.CrossRef Karve A, Hayward RA. Prevalence, diagnosis, and treatment of impaired fasting glucose and impaired glucose tolerance in nondiabetic U.S. adults. Diabetes Care 2010;33(11):2355–9.CrossRef
12.
go back to reference Schmittdiel JA, Adams SR, Segal J, Griffin MR, Roumie CL, Ohnsorg K, et al. Novel use and utility of integrated electronic health records to assess rates of prediabetes recognition and treatment: brief report from an integrated electronic health records pilot study. Diabetes Care 2014;37(2):565–8.CrossRef Schmittdiel JA, Adams SR, Segal J, Griffin MR, Roumie CL, Ohnsorg K, et al. Novel use and utility of integrated electronic health records to assess rates of prediabetes recognition and treatment: brief report from an integrated electronic health records pilot study. Diabetes Care 2014;37(2):565–8.CrossRef
13.
go back to reference Moin T, Li J, Duru OK, Ettner S, Turk N, Keckhafer A, et al. Metformin Prescription for Insured Adults With Prediabetes From 2010 to 2012: A Retrospective Cohort Study. Ann Intern Med 2015;162(8):542–8.CrossRef Moin T, Li J, Duru OK, Ettner S, Turk N, Keckhafer A, et al. Metformin Prescription for Insured Adults With Prediabetes From 2010 to 2012: A Retrospective Cohort Study. Ann Intern Med 2015;162(8):542–8.CrossRef
14.
go back to reference Tseng E, Greer RC, O’Rourke P, Yeh HC, McGuire MM, Clark JM, et al. Survey of primary care providers’ knowledge of screening for, diagnosing and managing prediabetes. J Gen Intern Med 2017;32(11):1172–1178.CrossRef Tseng E, Greer RC, O’Rourke P, Yeh HC, McGuire MM, Clark JM, et al. Survey of primary care providers’ knowledge of screening for, diagnosing and managing prediabetes. J Gen Intern Med 2017;32(11):1172–1178.CrossRef
15.
go back to reference Chan WV, Pearson TA, Bennett GC, Cushman WC, Gaziano TA, Gorman PN, et al. ACC/AHA Special Report: Clinical practice Guideline Implementation Science Work Group: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines. J Am Coll Cardiol 2017;69(8):1076–1092.CrossRef Chan WV, Pearson TA, Bennett GC, Cushman WC, Gaziano TA, Gorman PN, et al. ACC/AHA Special Report: Clinical practice Guideline Implementation Science Work Group: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines. J Am Coll Cardiol 2017;69(8):1076–1092.CrossRef
17.
go back to reference American Diabetes Association. Prevention or Delay of Type 2 Diabetes. Diabetes Care 2017;40(Suppl 1):S44-S7.CrossRef American Diabetes Association. Prevention or Delay of Type 2 Diabetes. Diabetes Care 2017;40(Suppl 1):S44-S7.CrossRef
18.
go back to reference American Diabetes Association. Classification and diagnosis of diabetes. Diabetes Care 2018;Suppl 1:S13-S27. American Diabetes Association. Classification and diagnosis of diabetes. Diabetes Care 2018;Suppl 1:S13-S27.
20.
go back to reference Maruthur NM, Ma Y, Delahanty LM, Nelson JA, Aroda V, White NH, et al. Early response to preventive strategies in the Diabetes Prevention Program. J Gen Intern Med 2013;28(12):1629–36.CrossRef Maruthur NM, Ma Y, Delahanty LM, Nelson JA, Aroda V, White NH, et al. Early response to preventive strategies in the Diabetes Prevention Program. J Gen Intern Med 2013;28(12):1629–36.CrossRef
21.
go back to reference Kandula NR, Moran MR, Tang JW, O’Brien MJ. Preventing Diabetes in Primary Care: Providers’ Perspectives About Diagnosing and Treating Prediabetes. Clin Diabetes 2018;36(1):59–66.CrossRef Kandula NR, Moran MR, Tang JW, O’Brien MJ. Preventing Diabetes in Primary Care: Providers’ Perspectives About Diagnosing and Treating Prediabetes. Clin Diabetes 2018;36(1):59–66.CrossRef
22.
go back to reference Mainous AG, 3rd, Tanner RJ, Baker R. Prediabetes Diagnosis and Treatment in Primary Care. J Am Board Fam Med 2016;29(2):283–5.CrossRef Mainous AG, 3rd, Tanner RJ, Baker R. Prediabetes Diagnosis and Treatment in Primary Care. J Am Board Fam Med 2016;29(2):283–5.CrossRef
23.
go back to reference Jay M, Gillespie C, Schlair S, Sherman S, Kalet A. Physicians’ use of the 5As in counseling obese patients: is the quality of counseling associated with patients’ motivation and intention to lose weight? BMC Health Serv Res 2010;10:159.CrossRef Jay M, Gillespie C, Schlair S, Sherman S, Kalet A. Physicians’ use of the 5As in counseling obese patients: is the quality of counseling associated with patients’ motivation and intention to lose weight? BMC Health Serv Res 2010;10:159.CrossRef
24.
go back to reference Huang J, Yu H, Marin E, Brock S, Carden D, Davis T. Physicians’ weight loss counseling in two public hospital primary care clinics. Acad Med 2004;79(2):156–61.CrossRef Huang J, Yu H, Marin E, Brock S, Carden D, Davis T. Physicians’ weight loss counseling in two public hospital primary care clinics. Acad Med 2004;79(2):156–61.CrossRef
25.
go back to reference Post RE, Mainous AG, 3rd, Gregorie SH, Knoll ME, Diaz VA, Saxena SK. The influence of physician acknowledgment of patients’ weight status on patient perceptions of overweight and obesity in the United States. Arch Intern Med 2011;171(4):316–21.CrossRef Post RE, Mainous AG, 3rd, Gregorie SH, Knoll ME, Diaz VA, Saxena SK. The influence of physician acknowledgment of patients’ weight status on patient perceptions of overweight and obesity in the United States. Arch Intern Med 2011;171(4):316–21.CrossRef
26.
go back to reference Rose SA, Poynter PS, Anderson JW, Noar SM, Conigliaro J. Physician weight loss advice and patient weight loss behavior change: a literature review and meta-analysis of survey data. Int J Obes 2013;37(1):118–28.CrossRef Rose SA, Poynter PS, Anderson JW, Noar SM, Conigliaro J. Physician weight loss advice and patient weight loss behavior change: a literature review and meta-analysis of survey data. Int J Obes 2013;37(1):118–28.CrossRef
27.
go back to reference Tseng E, Yeh HC, Maruthur NM. Metformin Use in Prediabetes among U.S. Adults, 2005-2012. Diabetes Care 2017;40(7):887–93.CrossRef Tseng E, Yeh HC, Maruthur NM. Metformin Use in Prediabetes among U.S. Adults, 2005-2012. Diabetes Care 2017;40(7):887–93.CrossRef
32.
go back to reference Chaudhry B, Wang J, Wu S, Maglione M, Mojica W, Roth E, et al. Systematic review: impact of health information technology on quality, efficiency, and costs of medical care. Ann Intern Med 2006;144(10):742–52.CrossRef Chaudhry B, Wang J, Wu S, Maglione M, Mojica W, Roth E, et al. Systematic review: impact of health information technology on quality, efficiency, and costs of medical care. Ann Intern Med 2006;144(10):742–52.CrossRef
33.
go back to reference Meigs JB, Cagliero E, Dubey A, Murphy-Sheehy P, Gildesgame C, Chueh H, et al. A controlled trial of web-based diabetes disease management: the MGH diabetes primary care improvement project. Diabetes Care 2003;26(3):750–7.CrossRef Meigs JB, Cagliero E, Dubey A, Murphy-Sheehy P, Gildesgame C, Chueh H, et al. A controlled trial of web-based diabetes disease management: the MGH diabetes primary care improvement project. Diabetes Care 2003;26(3):750–7.CrossRef
34.
go back to reference Raz DJ, Wu GX, Consunji M, Nelson R, Sun C, Erhunmwunsee L, et al. Perceptions and Utilization of Lung Cancer Screening Among Primary Care Physicians. J Thorac Oncol 2016;11(11):1856–62.CrossRef Raz DJ, Wu GX, Consunji M, Nelson R, Sun C, Erhunmwunsee L, et al. Perceptions and Utilization of Lung Cancer Screening Among Primary Care Physicians. J Thorac Oncol 2016;11(11):1856–62.CrossRef
35.
go back to reference Venkataramani M, Cheng TL, Solomon BS, Pollack CE. Addressing Parental Health in Pediatrics: Physician Perceptions of Relevance and Responsibility. Clin Pediatr (Phila) 2017;56(10):953–8.CrossRef Venkataramani M, Cheng TL, Solomon BS, Pollack CE. Addressing Parental Health in Pediatrics: Physician Perceptions of Relevance and Responsibility. Clin Pediatr (Phila) 2017;56(10):953–8.CrossRef
36.
go back to reference Xierali IM, Nivet MA. The racial and ethnic composition and distribution of primary care physicians. J Health Care Poor Underserved 2018;29(1):556–570.CrossRef Xierali IM, Nivet MA. The racial and ethnic composition and distribution of primary care physicians. J Health Care Poor Underserved 2018;29(1):556–570.CrossRef
37.
go back to reference Petterson S, McNellis R, Klink K, Meyers D, Bazemore A. The State of Primary Care in the United States: A Chartbook of Facts and Statistics. 2018. Petterson S, McNellis R, Klink K, Meyers D, Bazemore A. The State of Primary Care in the United States: A Chartbook of Facts and Statistics. 2018.
38.
go back to reference Wright JD, Marsden PV. Handbook of Survey Research. 2nd ed. San Diego, CA: Elsevier; 2010. Wright JD, Marsden PV. Handbook of Survey Research. 2nd ed. San Diego, CA: Elsevier; 2010.
39.
go back to reference O’Brien MJ, Moran MR, Tang JW, Vargas MC, Talen M, Zimmermann LJ, et al. Patient Perceptions About Prediabetes and Preferences for Diabetes Prevention. Diabetes Educ 2016;42(6):667–77.CrossRef O’Brien MJ, Moran MR, Tang JW, Vargas MC, Talen M, Zimmermann LJ, et al. Patient Perceptions About Prediabetes and Preferences for Diabetes Prevention. Diabetes Educ 2016;42(6):667–77.CrossRef
Metadata
Title
National Survey of Primary Care Physicians’ Knowledge, Practices, and Perceptions of Prediabetes
Authors
Eva Tseng, MD
Raquel C. Greer, MD
Paul O’Rourke, MD
Hsin-Chieh Yeh, PhD
Maura M. McGuire, MD
Ann L. Albright, PhD
Jill A. Marsteller, PhD
Jeanne M. Clark, MD
Nisa M. Maruthur, MD
Publication date
01-11-2019
Publisher
Springer US
Published in
Journal of General Internal Medicine / Issue 11/2019
Print ISSN: 0884-8734
Electronic ISSN: 1525-1497
DOI
https://doi.org/10.1007/s11606-019-05245-7

Other articles of this Issue 11/2019

Journal of General Internal Medicine 11/2019 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.